130 related articles for article (PubMed ID: 31300837)
1. Disproportionality analysis for identification of drug safety signals in a database shared by the Norwegian network of drug information centres (RELIS).
Stokes CL; Schjøtt J
Eur J Clin Pharmacol; 2019 Oct; 75(10):1469-1470. PubMed ID: 31300837
[No Abstract] [Full Text] [Related]
2. Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems.
Schjøtt J; Bergman J
Drug Healthc Patient Saf; 2014; 6():89-92. PubMed ID: 25061339
[TBL] [Abstract][Full Text] [Related]
3. Physicians' questions concerning drug use among older patients: experience from Norwegian drug information centres (RELIS) in the period 2010-2015.
Schjøtt J
Aging Clin Exp Res; 2018 Jul; 30(7):867-870. PubMed ID: 28929445
[TBL] [Abstract][Full Text] [Related]
4. Benefits of a national network of drug information centres: RELIS.
Schjøtt J
Eur J Clin Pharmacol; 2017 Jan; 73(1):125-126. PubMed ID: 27637913
[No Abstract] [Full Text] [Related]
5. [RELIS--a Norwegian database with free, problem-based drug information for health care].
Frost S; Mehlum LI
Lakartidningen; 2003 Sep; 100(38):2957. PubMed ID: 14558219
[No Abstract] [Full Text] [Related]
6. The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review.
Dias P; Penedones A; Alves C; Ribeiro CF; Marques FB
Curr Drug Saf; 2015; 10(3):234-50. PubMed ID: 26219291
[TBL] [Abstract][Full Text] [Related]
7. Abuse and misuse of second-generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance database.
Roy S; Charreteur R; Peries M; Kheloufi F; Eiden C; Nagot N; Donnadieu-Rigole H; Micallef J; Peyrière H
Br J Clin Pharmacol; 2022 Oct; 88(10):4646-4653. PubMed ID: 35633029
[TBL] [Abstract][Full Text] [Related]
8. An Alternative to Disproportionality: A Frequency-Based Method for Pharmacovigilance Data Mining.
Jokinen JD; Lievano F; Scarazzini L; Truffa M
Ther Innov Regul Sci; 2018 May; 52(3):294-299. PubMed ID: 29714535
[TBL] [Abstract][Full Text] [Related]
9. Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database.
Bossard JB; Ponté C; Dupouy J; Lapeyre-Mestre M; Jouanjus E
Clin Drug Investig; 2016 Sep; 36(9):735-742. PubMed ID: 27300651
[TBL] [Abstract][Full Text] [Related]
10. Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluation.
Hauben M; Reich L
J Clin Pharmacol; 2005 Apr; 45(4):378-84. PubMed ID: 15778418
[TBL] [Abstract][Full Text] [Related]
11. Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance.
Zink RC; Huang Q; Zhang LY; Bao WJ
Chin J Nat Med; 2013 May; 11(3):314-20. PubMed ID: 23725848
[TBL] [Abstract][Full Text] [Related]
12. Exploration of statistical shrinkage parameters of disproportionality methods in spontaneous reporting system of China.
Wang J; Ye XF; Guo XJ; Zhu TT; Qi N; Hou YF; Zhang TY; Shi WT; Wei X; Liu YZ; Wu GZ; He J
Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):962-70. PubMed ID: 26095121
[TBL] [Abstract][Full Text] [Related]
13. [Role and Applicability of Spontaneous Reporting Databases in Medical Big Data].
Sakai T
Yakugaku Zasshi; 2021; 141(2):165-168. PubMed ID: 33518634
[TBL] [Abstract][Full Text] [Related]
14. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
15. Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases.
Johnson K; Guo C; Gosink M; Wang V; Hauben M
Bioinformatics; 2012 Dec; 28(23):3123-30. PubMed ID: 23064001
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.
Kimura G; Kadoyama K; Brown JB; Nakamura T; Miki I; Nisiguchi K; Sakaeda T; Okuno Y
Int J Med Sci; 2015; 12(2):135-40. PubMed ID: 25589889
[TBL] [Abstract][Full Text] [Related]
17. [Problem-oriented drug information: the RELIS database, a free drug information on the Internet for Scandinavian health professionals].
Mehlum LI; Frost SK
Ugeskr Laeger; 2004 Aug; 166(34):2886-7. PubMed ID: 15449525
[No Abstract] [Full Text] [Related]
18. Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database.
Chiappini S; Schifano F
J Clin Psychopharmacol; 2018 Feb; 38(1):72-79. PubMed ID: 29210868
[TBL] [Abstract][Full Text] [Related]
19. Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study.
Schjøtt J; Erdal H
BMC Complement Altern Med; 2014 Feb; 14():56. PubMed ID: 24529279
[TBL] [Abstract][Full Text] [Related]
20. Data mining spontaneous adverse drug event reports for safety signals in Singapore - a comparison of three different disproportionality measures.
Ang PS; Chen Z; Chan CL; Tai BC
Expert Opin Drug Saf; 2016 May; 15(5):583-90. PubMed ID: 26996192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
